Patents by Inventor Eiji MIYAUCHI

Eiji MIYAUCHI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240142876
    Abstract: A method for manufacturing a semiconductor substrate, includes: directly or indirectly applying a composition for forming a resist underlayer film to a substrate to form a resist under film directly or indirectly on the substrate; applying a composition for forming a resist film to the resist underlayer film to form a resist film on the resist underlayer film; exposing the resist film to radiation; and developing the exposed resist film by a developer. The composition for forming a resist underlayer film includes: a polymer; an onium salt that is capable of generating at least one polar group selected from the group consisting of a carboxy group and a hydroxy group by radiation or heat; and a solvent.
    Type: Application
    Filed: December 5, 2023
    Publication date: May 2, 2024
    Applicant: JSR CORPORATION
    Inventors: Hiroyuki MIYAUCHI, Satoshi DEI, Ryotaro TANAKA, Eiji YONEDA, Sho YOSHINAKA
  • Publication number: 20240105451
    Abstract: A method for manufacturing a semiconductor substrate, includes: directly or indirectly applying a composition for forming a resist underlayer film to a substrate to form a resist underlayer film; applying a composition for forming a resist film to the resist underlayer film to form a resist film; exposing the resist film to radiation; and developing the exposed resist film. The composition for forming a resist underlayer film includes: a polymer; an acid generating agent; and a solvent. The resist underlayer film has a film thickness of 6 nm or less.
    Type: Application
    Filed: November 15, 2023
    Publication date: March 28, 2024
    Applicant: JSR CORPORATION
    Inventors: Eiji YONEDA, Takayoshi ABE, Hiroyuki MIYAUCHI
  • Patent number: 11896043
    Abstract: Object of the present invention is to provide an intestinal immune-enhancing agent that can sufficiently increase IgA in the intestinal tract with a low dose while maintaining an increased amount of IgA for an extended period of time. Provided is an intestinal immune-enhancing agent containing a cellulose acetate that has a total degree of acetyl substitution from 0.4 to 1.1.
    Type: Grant
    Filed: September 15, 2021
    Date of Patent: February 13, 2024
    Assignee: DAICEL CORPORATION
    Inventors: Tadashi Takeuchi, Eiji Miyauchi, Shu Shimamoto, Akinobu Matsuyama, Hiroshi Ohno
  • Publication number: 20220061372
    Abstract: Object of the present invention is to provide an intestinal immune-enhancing agent that can sufficiently increase IgA in the intestinal tract with a low dose while maintaining an increased amount of IgA for an extended period of time. Provided is an intestinal immune-enhancing agent containing a cellulose acetate that has a total degree of acetyl substitution from 0.4 to 1.1.
    Type: Application
    Filed: September 15, 2021
    Publication date: March 3, 2022
    Applicant: DAICEL CORPORATION
    Inventors: Tadashi TAKEUCHI, Eiji MIYAUCHI, Shu SHIMAMOTO, Akinobu MATSUYAMA, Hiroshi OHNO
  • Publication number: 20210379097
    Abstract: An object is to provide a Th1-increasing agent that can reduce constraints on storage conditions and feeding form and sufficiently increase Th1 at lower doses. A Th1-increasing agent containing a cellulose derivative as an active ingredient, the cellulose derivative having a degree of butyryl substitution of 0.3 or greater and 2.6 or less, and a total degree of substitution of 0.5 or greater and 2.8 or less.
    Type: Application
    Filed: October 24, 2019
    Publication date: December 9, 2021
    Applicant: DAICEL CORPORATION
    Inventors: Hiroshi OHNO, Tadashi TAKEUCHI, Shu SHIMAMOTO, Shuuji YOSHIOKA, Eiji MIYAUCHI, Hiroki NEGISHI
  • Publication number: 20200288762
    Abstract: Object of the present invention is to provide an intestinal immune-enhancing agent that can sufficiently increase IgA in the intestinal tract with a low dose while maintaining an increased amount of IgA for an extended period of time. Provided is an intestinal immune-enhancing agent containing a cellulose acetate that has a total degree of acetyl substitution from 0.4 to 1.1.
    Type: Application
    Filed: October 23, 2018
    Publication date: September 17, 2020
    Applicant: DAICEL CORPORATION
    Inventors: Tadashi TAKEUCHI, Eiji MIYAUCHI, Shu SHIMAMOTO, Akinobu MATSUYAMA, Hiroshi OHNO